Department of Pharmacology, University of Virginia, Charlottesville, Virginia 22908
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Li, Yu-Wen, Patrice G. Guyenet, and Douglas A. Bayliss. Voltage-dependent calcium currents in bulbospinal neurons of neonatal rat rostral ventrolateral medulla: modulation by 2-adrenergic receptors. J. Neurophysiol. 79: 583-594, 1998. The properties and modulation by norepinephrine (NE) of voltage-dependent calcium currents were studied in bulbospinal neurons (n = 116) of the rostral ventrolateral medulla (RVLM) using whole cell patch-clamp techniques in neonatal rat brain stem slices. RVLM bulbospinal neurons were identified visually by their location in slices and by the presence of flourescein isothiocyanate-tagged microbeads, which were injected into the spinal cord before the experiment; RVLM neurons were filled with Lucifer yellow during recordings, and the slice was processed for detection of tyrosine hydroxylase immunoreactivity (TH-IR). Thirty-four of 42 recovered cells (81%) were positive for TH-IR, indicating that most recorded cells were C1 neurons. Bulbospinal RVLM neurons expressed a prominent high-voltage-activated (HVA) calcium current, which began to activate at
30 to
40 mV (from a holding potential of
60 or
70 mV), and peaked at ~0 mV (0.8 ± 0.1 nA;mean ± SE). HVA current comprised predominantly
-conotoxin GVIA-sensitive, N-type and
-agatoxin IVA-sensitive, P/Q-type components, with smaller dihydropyridine-sensitive, L-type, and residual current components. Most RVLM bulbospinal neurons (n = 44/52, including 12/14 histologically identified C1 cells) also expressed low-voltage-activated (LVA) calcium current. LVA current began to activate at ~
60 mV (from a holding potential of
100 mV) and was nearly completely inactivated at
50 mV with a half-inactivation potential of
70 ± 2 mV. The amplitude of LVA current at
50 mV was 78 ± 24 pA with Ba2+ and 156 ± 38 pA with Ca2+ as a charge carrier. NE inhibited HVA current in most bulbospinal RVLM neurons (n = 70/77) with an EC50 of 1.2 µM; NE had no effect on LVA current. Calcium current inhibition by NE was mediated by
2-adrenergic receptors (
2-ARs) as the effect was mimicked by the selective
2-AR agonist, UK-14,304, and blocked by idazoxan, an
2-AR antagonist, but unaffected by prazosin and propranolol (
1- and
-AR antagonists, respectively). Most of the NE-sensitive calcium current was N- and P/Q-type. NE-induced inhibition of calcium current evoked by action potential waveforms (APWs) was significantly larger than that evoked by depolarizing steps (34 ± 2.5 vs. 23 ± 2.7%; P < 0.05). Although inhibition of calcium current was voltage dependent and partially relieved by strong depolarizations, when calcium currents were evoked with a 10-Hz train of APWs as a voltage command, the inhibitory effect of NE was maintained throughout the train. In conclusion, bulbospinal RVLM neurons, including C1 cells, express multiple types of calcium currents. Inhibition of HVA calcium current by NE may modulate input-output relationships and release of transmitters from C1 cells.
Central neurons possess multiple types of voltage-gated calcium channels (Bean 1989 Retrograde labeling of bulbospinal neurons in the RVLM
The procedures for retrogradely labeling bulbospinal neurons in the RVLM and for preparing brain slices were as described previously (Bayliss et al. 1997a Preparation of brain stem slices
Two to five days after the spinal injections, the rats (3-8 day postnatal) were anesthetized deeply by hypothermia and decapitated. The lower brain stem was removed quickly and immersed in an ice-cold Ringer solution (see following section for composition of solutions) and sectioned into transverse slices (150 µm) using a microslicer (DSK-1500E, Dosaka). Slices were incubated for 1 h at 37°C and then maintained at room temperature (22-25°C) in the Ringer solution.
Solutions and drugs
The solution used for preparing slices contained (in mM) 130 NaCl, 3 KCl, 5 MgCl2, 1 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 glucose (equilibrated with 95%O2-5% CO2). For incubation of slices, the solution was the same except that CaCl2 and MgCl2 were both at 2 mM and lactic acid was added (4 mM). The external solution used for recording barium currents through calcium channels contained (in mM) 140 NaCl, 3 KCl, 10 N-[2-hydroxyethyl-piperazine]-N Recording and data analysis
Slices were submerged in a chamber mounted on a fixed-stage fluorescence microscope (Axioskop FS, Zeiss) equipped with Nomarski optics and a ×40 water-immersion objective. Neurons selected for recording were located in the rostral ventrolateral medulla at the level of the rostral tip of the inferior olive. Bulbospinal neurons in the RVLM were identified by the presence of FITC-tagged beads in the cell bodies. Patch electrodes were fabricated from borosilicate glass (Clark Electromedical, UK) on a horizontal puller (Sutter P-97) to a DC resistance of 4-7 M Immunohistochemical detection of tyrosine hydroxylase
Recorded bulbospinal neurons were marked during the experiment by including Lucifer yellow (0.02%) in the pipette solution. Slices containing recorded cells were immersed in 4% paraformaldehyde solution for 1-4 days before they were processed by immunohistochemical staining for tyrosine hydroxylase (TH, the rate-limiting catecholamine-synthesizing enzyme), as described (Li et al. 1996 The present report is based on whole cell recordings from 116 RVLM neurons; all recorded neurons were bulbospinal (i.e., retrogradely labeled with FITC-tagged microbeads from the thoracic spinal cord). We recovered a subset of recorded bulbospinal neurons (n = 42) after histological processing for TH-immunoreactivity (TH-IR); of those 42 neurons, the majority was TH-IR (n = 34, 81%). An example of a bulbospinal TH-IR neuron is shown in Fig. 1.
HVA calcium currents
Whole cell calcium channel currents were recorded using Ba2+ as a charge carrier under conditions that minimize K+ and Na+ currents. As shown in Fig. 2A, depolarizing steps from a holding potential of
Pharmacology of HVA current
HVA current can be subdivided into several components based on sensitivity to selective calcium channel antagonists (Dunlap et al. 1995 LVA calcium current
To characterize LVA current in bulbospinal RVLM cells, we used the two-pulse voltage protocol shown in Fig. 3A in which currents were evoked at potentials between
NE inhibits HVA, but not LVA, currents
We have demonstrated previously that RVLM bulbospinal cells, and particularly C1 neurons, express functional
We performed experiments to determine the adrenergic receptor subtype that mediates calcium current inhibition by NE in bulbospinal RVLM neurons. First, we compared the effect of 10 µM NE in the absence and presence of prazosin and propranolol (
NE inhibits N- and P/Q-types of HVA calcium current
We demonstrated above that RVLM bulbospinal neurons express N- and P/Q-type calcium currents. Therefore, we wished to determine the sensitivity of these two major components of calcium current to NE. As shown in the representative experiment of Fig. 7A, NE (10 µM) caused 37% inhibition of calcium channel current under control conditions. After blocking N-type channels with 1 µM CgTx, the NE-induced inhibition was reduced to 9%. After further block of P/Q-type current with 0.2 µM AgaTx, the inhibition essentially was abolished (<2%). Therefore 75% of NE-sensitive current in this neuron was N-type and 21% was P/Q-type. Averaged data from six cells are shown in Fig. 7B. Of ~28% of HVA current that was sensitive to NE, 51 ± 9% was N-type and 41 ± 5% was P/Q-type; NE inhibited 36 ± 4% of N-type current compared with 30 ± 6% of P/Q-type. Very little NE-sensitive current remained after blocking N- and P/Q-type currents, suggesting that L-type and residual components do not contribute substantially to calcium current inhibition by NE.
Effect of NE on calcium currents evoked by action potential waveforms
We found that inhibition of HVA calcium current by NE is voltage and time dependent. This suggests that transmitter-induced modulation of calcium currents in RVLM cells may be enhanced when calcium currents are evoked by APWs instead of depolarizing pulses (Pennington et al. 1992; Toth and Miller 1995
The present study provides the first description of calcium currents in bulbospinal RVLM neurons, including C1 cells, and their modulation by NE. RVLM neurons express a relatively sustained HVA current, comprising prominent N- and P/Q-type components and smaller L-type and residual components. A transient LVA current, which began to activate at Methodological considerations
Some methodological considerations are noteworthy. First, by necessity, brain stem slices were derived from neonatal rats. With current technology, targeting retrogradely labeled neurons under direct vision in the heavily reticulated RVLM region of adult animals is extremely difficult, if not impossible. So, although this is the first description of calcium channels in bulbospinal RVLM neurons, it is notcertain that the complement of channels we have describedand/or the mechanism of their modulation would be identical in these same neurons from adult rat.
HVA calcium currents
HVA calcium currents recorded in bulbospinal RVLM neurons, including C1 cells, have properties similar to those found in many other neurons. HVA current activated with a threshold at approximately LVA calcium currents
The majority of RVLM bulbospinal neurons tested(44/52), including all 12 verified C1 neurons, expressed a transient calcium current that displayed kinetic properties similar to those of LVA calcium currents described in other neurons (Huguenard 1996 NE inhibits HVA current by activation of We found that NE inhibited HVA current but had no apparent effect on LVA current. The selective inhibition of HVA calcium current by NE is in good agreement with observations in other neurons (Allen and Brown 1993 Effects of NE on calcium currents evoked by APWs
Calcium currents and their neuromodulation traditionally have been studied by applying rectangular depolarizing pulses and recording the resultant currents. However, several groups recently have used APWs as a voltage command to more closely mimic the "physiological" situation (Brody et al. 1997 Functional implications of calcium current inhibition by The coupling of
INTRODUCTION
Abstract
Introduction
Methods
Results
Discussion
References
; Dunlap et al. 1995
; Huguenard 1996
; Llinas 1988
). Based on differences in voltage-dependent activation and inactivation properties, calcium currents have been subdivided into low-voltage-activated (LVA) and high-voltage-activated (HVA) components (Carbone and Swandulla 1993
). LVA current activates at relatively hyperpolarized potentials and inactivates more rapidly than HVA currents (Huguenard 1996
). HVA currenthas been further subdivided into:
-conotoxin GVIA(CgTx)-sensitive, N-type component;
-agatoxin IVA(AgaTx)-sensitive P/Q-type component; dihydropyridine-sensitive L-type component; and a residual component (R type) that is insensitive to calcium channel antagonists (Dunlap et al. 1995
). Each calcium channel subtype may have a specialized physiological role. For example, N- and P/Q-type HVA currents are essential for neurotransmitter release from presynaptic terminals (Bean 1989
; Dunlap et al. 1995
; Takahashi and Momiyama 1993
) and contribute to activation of Ca2+-dependent K+ channels (Umemiya and Berger 1994
; Viana et al. 1993
). L-type HVA channels may be important for mediating effects of Ca2+ on gene expression (Bading et al. 1993
; Murphy et al. 1991
). Finally, because they operate at subthreshold levels of membrane potential, LVA currents are uniquely poised to contribute to intrinsic neuronal excitability and rhythmic activity (Huguenard 1996
; Llinas 1988
).
; Guyenet et al. 1996
). Although the mechanisms responsible for the generation of basal sympathetic tone are not fully understood, a contributing factor may be the intrinsic pacemaker activity of RVLM bulbospinal neurons (Guyenet et al. 1996
). In neonatal rat brain slices, for example, the spontaneous discharge of C1 neurons appears to be due to intrinsic properties rather than excitatory synaptic inputs (Li et al. 1996
). Currently, relatively little is known of the intrinsic properties of C1 and other RVLM bulbospinal neurons. In the neonatal rat, C1 neurons were found to express various voltage-dependent K+ currents and a hyperpolarization-activated cationic current (Kangrga and Loewy 1995
; Li et al. 1996
), but nothing is known regarding voltage-dependent calcium currents in this cell group. A description of the properties of these currents is, therefore, a major objective of the present report.
2A-adrenergic receptors (Guyenet et al. 1994
), and many bulbospinal RVLM vasomotor neurons in vivo are inhibited by activation of
2-adrenergic receptors (
2-ARs) (Allen and Guyenet 1993
). We have shown previously that activation of
2-ARs hyperpolarizes bulbospinal C1 adrenergic neurons of neonatal rats in vitro by activating an inwardly rectifying K+ conductance (Li et al. 1996
). In other neurons, norepinephrine (NE) also inhibits voltage-activated calcium channels via
2-ARs (Chen and Schofield 1993
; Ishibashi and Akaike 1995
; Li and Bayliss 1997; Trombley 1992
). Accordingly, in the present study, we tested effects of NE on calcium currents in RVLM bulbospinal neurons.
2-ARs inhibited primarily N- andP/Q-components of HVA current but had no effect on LVA current. NE-induced inhibition of calcium current was greater when calcium current was evoked by action potential waveforms instead of depolarizing steps. Thus, RVLM bulbospinal C1 neurons express multiple calcium channel types; calcium current inhibition by NE may contribute to autoregulation of these neurons by
2-AR agonists.
METHODS
Abstract
Introduction
Methods
Results
Discussion
References
,b
; Li et al. 1996
). Neonatal Sprague-Dawley rats (1-3 days postnatal) were anesthetized by hypothermia. The thoracic spinal cord was exposed using aseptic methods. A suspension of microspheres labeled with flourescein isothiocyanate (FITC-tagged microbeads, Lumafluor) was injected bilaterally into the upper thoracic spinal cord (0.5-0.8 µl total volume) using a calibrated glass pipette. The skin was closed with cyanoacrylate glue and the pups were returned to a lactating female.
-[2-ethanesulfonic acid] (HEPES), 2 BaCl2, 2 MgCl2, 10 glucose, and 0.001 tetrodotoxin (TTX; pH = 7.3 using NaOH). In some experiments, BaCl2 was replaced with equimolar CaCl2. The internal solution contained (in mM) 30 tetraethylammonium (TEA)Cl, 100 CsCH3O3S, 10 HEPES, 10 ethylene glycol-bis(
-aminoethyl ether)-N,N,N
,N
-tetraacetic acid, 4 NaCl, 1 MgCl2, 0.5 CaCl2, 3 ATP-Mg, and 0.3 GTP-tris(hydroxymethyl)aminomethane (GTP-Tris; pH = 7.2 using CsOH or TEAOH).
20°C; they were thawed and diluted to final working concentrations on the experimental day. NE (0.1-30 µM) was obtained from Sigma. UK-14,304 (1 µM), propranolol (1 µM), prazosin (1 µM), and idazoxan (1 µM) were obtained from Research Biochemicals International. TTX (1 µM) was from Calbiochem. Stock solutions of CgTx (Bachem) and AgaTx (generous gift from Pfizer, Groton, CT) were prepared and added to perfusate containing 0.1% cytochrome C. Toxins were used at concentrations previously shown to completely block nonoverlapping components of HVA calcium current (2 µM for CgTx and 0.2 µM for AgaTx) (Bayliss et al. 1997b
; Mintz et al. 1992
). This was verified in the present experiments as we found that the percentage of current sensitive to each toxin was independent of the order of toxin application.
and connected to the headstage of an Axopatch-200A patch-clamp amplifier (Axon Instruments). Signals were filtered at 2-5 kHz and digitized at 5-10 kHz. Series resistance was usually <20 M
and compensated by ~70%. Whole cell currents were recorded and analyzed using pClamp software (Axon Instruments). Electrical recordings were performed at room temperature. All recordings of calcium channel currents were leak-subtracted using a P/4 protocol. Because of the potential for voltage clamp errors when recording from intact neurons with extended processes, we were vigilant for cases when currents were obviously uncontrolled; we excluded from further analysis any currents that were not smooth and continuous functions of voltage and time.
70 mV. Difference currents obtained by digital subtraction of currents elicited during depolarizing voltage steps from
60 and
100 mV were used to define LVA currents. To test effects of NE or calcium channel toxins, HVA currents were elicited during 20-ms voltage steps to 0 mV from
70 mV at 12- to 20-s intervals. The peak current during the voltage step was measured under control conditions and then isochronally throughout the experiment. The percent current inhibition attributed to NE or calcium channel toxins was determined by comparing the current in NE or toxin to the initial control current. In all cases in which run-down was evident, the data were fitted with a linear function, and the current inhibition was calculated by comparing the current in the presence of NE or toxin to a point estimated based on the linear interpolation of the run-down. Kinetic slowing induced by NE was evaluated by comparing the percent inhibition early in the pulse, at the time of the control peak current, to that obtained at the end of the voltage step. To test whether current inhibition by NE was relieved by strong depolarizations, we used a protocol in which a test pulse to 0 mV was generated before and then after a step to +70 mV. To record currents evoked by action potential waveforms (APWs), action potentials were recorded from bulbospinal RVLM neurons in current-clamp configuration and used to create a voltage command template.
). After rinses in 0.1 M phosphate buffer (PB) and 1% sodium borohydride in PB, slices were incubated in mouse monoclonal antibody to TH (1:500) in Tris solution (50 mM Tris, 150 mM NaCl, pH 7.4) containing 5% normal goat serum and 0.5% Triton-100 (TS/NGS/TX) for 12-48 h at 4°C. After rinses inTS/NGS/TX, sections were incubated for 1 h at room temperature with biotinylated rabbit anti-mouse antisera (1:100; Vector) inTS/NGS/TX and then incubated for 1 h at room temperaturewith avidin-Texas red conjugate (1:200; Molecular Probes) in TS. After rinses in Tris solution, sections were mounted on gelatin-coated slides and coverslipped in Krystalon (EM Science) before they were examined and photographed with a Zeiss fluorescence microscope.
RESULTS
Abstract
Introduction
Methods
Results
Discussion
References
View larger version (61K):
[in a new window]
FIG. 1.
Bulbospinal C1 neuron recorded in the rostral ventrolateral medulla (RVLM). Bulbospinal neurons in the RVLM were identified by the presence of flourescein isothiocyanate (FITC)-tagged microbeads that were injected into the spinal cord 2-5 days before the experiment. Recorded neurons were filled with Lucifer yellow through the recording pipettes and immunostained for tyrosine hydroxylase, a catecholamine-synthesizing enzyme. A: fluorescence photomicrograph of a recorded RVLM bulbospinal neuron marked by Lucifer yellow ( ). Note the presence of microbeads in the cell body and dendrites. B: fluorescence photomicrograph of Texas red-stained tyrosine hydroxylase immunoreactivity (TH-IR) neurons. Recorded bulbospinal neuron (
) was TH-IR, indicating that it was a C1 neuron. An adjacent TH-IR neuron that was not recorded also was labeled by FITC-tagged microbeads (
). Scale bar, 20 µM.
70 mV evoked relatively sustained inward currents in a RVLM bulbospinal neuron. The corresponding current-voltage (I-V) relationship (Fig. 2B, diamonds) reveals that the current began to activate between
40 and
30 mV and peaked at 0 mV with a maximal amplitude of ~1.2 nA. The current was blocked completely by 100 µM Cd2+, a calcium channel blocker (Fig. 2B, squares). HVA current was observed in all bulbospinal RVLM neurons tested; on average, it activated at
40 to
30 mV (from holding potentials of
60 or
70 mV) and had a peak amplitude of 0.8 ± 0.1 nA at 0 mV (n = 26). Of the 26 bulbospinal neurons in this group, 14 were recovered after histological processing; 12 of those 14 were positive for TH-IR, suggesting that they were C1 neurons.
View larger version (20K):
[in a new window]
FIG. 2.
High-voltage-activated (HVA) calcium current. A: HVA calcium channel currents were recorded from a RVLM bulbospinal neuron during depolarizing steps (10-mV increments) from a holding potential of 70 mV. B: current-voltage (I-V) relationship for calcium channel currents recorded in the same cell in control and in the presence of 100 µM Cd2+. C: effects of calcium channel antagonists. Peak currents (evoked at 0 mV from a holding potential of
70 mV) were measured and plotted as a function of time.
-conotoxin GVIA (CgTx, 2 µM),
-agatoxin IVA (AgaTx, 0.2 µM), nimodipine (nimo, 10 µM) and Cd2+ (100 µM) were applied at the times indicated. D: I-V relationships for calcium channel currents recorded in a different bulbospinal neuron in response to bath application of AgaTx (0.2 µM) and CgTx (2 µM).
). To determine which subtypes of HVA calcium channels are expressed in RVLM bulbospinal neurons, we examined the effects of several calcium channel antagonists, as shown in Fig. 2C. HVA current was evoked at 0 mV from
70 mV, and the peak amplitude of the current was plotted as a function of time. In this cell, bath application of 2 µM CgTx, an N-type channel antagonist, inhibited 38% of HVA current. Subsequent application of 0.2 µM AgaTx, a P/Q-type channel antagonist, produced a further 30% decrease in the current. The inhibition was maintained after wash of both toxins, consistent with an irreversible block of N- and P/Q-type channels by these toxins. After CgTx and AgaTx, application of the L-type channel antagonist nimodipine (10 µM) caused an additional 8% inhibition of the current. The residual current (24% in this case) was abolished completely by 100 µM Cd2+. Figure 2D shows the effects of AgaTx and CgTx on the I-V relationship for HVA current in a different RVLM bulbospinal neuron. In this cell, AgaTx and CgTx inhibited 28 and 31%, respectively, of HVA current evoked at 0 mV from
70 mV. The current inhibition induced by these toxins was not associated with any apparent shift in the I-V relationship. In 10 bulbospinal neurons tested, the CgTx-sensitive N-type and the AgaTx-sensitive P/Q-type components accounted for 45 ± 4.4% and 33 ± 3.7% of HVA current, respectively. The L-type component contributed 10 ± 1.2% (n = 10), and a residual component resistant to all three antagonists represented12 ± 2.1% of the total HVA current (n = 5).
50 and
30 mV after a 1-s prepulse to
100 mV and then from a holding potential of
60 mV. Currents evoked from
100 mV were of moderate amplitude (40-150 pA) and inactivated rapidly. By contrast, from a holding potential of
60 mV, essentially no current was evoked at
40 or
50 mV and only a small sustained current was evident at
30 mV. Digital subtraction of currents evoked from
60 mV from those evoked after the prepulse to
100 mV resulted in the prepulse-sensitive currents (Fig. 3A, inset). The amplitude and kinetics of the prepulse-sensitive currents were virtually identical to the transient components of currents evoked from
100 mV, suggesting that the transient components of the currents evoked at
50 to
30 mV from
100 mV were predominantly LVA current. The mean amplitude of LVA current evoked at
60,
50, and
40 mV from
100 mV in 12 RVLM bulbospinal neurons was 31 ± 6 pA, 51 ± 9 pA, and 70 ± 14 pA, respectively.
View larger version (17K):
[in a new window]
FIG. 3.
Low-voltage-activated (LVA) calcium current. A: transient and sustained calcium channel currents were recorded from a RVLM bulbospinal neuron using the voltage protocol shown on top trace. Currents were evoked at 50,
40, and
30 mV, first following a prepulse (1-s) to
100 mV and then after a prepulse (0.1 s) to
60 mV. Inset: transient currents obtained by digital-subtraction of currents evoked from
60 mV from those evoked from
100 mV. B: steady state inactivation of LVA current in a bulbospinal neuron. Peak amplitude of currents evoked at
50 mV were normalized, plotted against prepulse potential, and a Boltzman function was fitted to the data (see text). Half-inactivation voltage (V1/2) for this neuron was
70 mV, and the slope factor was 6 mV. Inset: currents evoked at
50 mV after prepulses to different potentials (10-mV increments from
100 mV) in the same cell. C: replacing Ba2+ (2 mM) with equimolar calcium increased the peak amplitude of LVA current, but had no effect on the kinetics of the current (see inset). LVA currents were evoked at
50 mV from
100 mV.
50 mV after a 1-s prepulse that varied from
100 mV to
40 mV (Fig. 3C, inset). Peak currents during the depolarizing step were measured, normalized, and plotted as a function of the prepulse potential, as shown in Fig. 3B. The data points were fitted with a Boltzman equation: y = {1 + exp[(V
V1/2)/k]}
1, where V is the prepulse potential, V1/2 is the half-inactivation potential, and k is a slope factor. Inactivation of the LVA current was steeply voltage dependent between
80 and
60 mV, with a half-inactivation potential about
70 mV and a slope factor of 6 mV. LVA currents were inactivated almost completely at potentials greater than or equal to
50 mV. In four RVLM bulbospinal cells tested, the half-inactivation potential was
70 ± 2 mV and the slope factor was 6 ± 0.1 mV.
). For example, with Ca2+ instead of Ba2+ as the charge carrier, LVA currents are larger in thalamic reticular neurons but not different in lateral habenula neurons (Huguenard et al. 1993
). Because Ca2+ is the physiologically relevant ion, we decided to examine this issue in RVLM bulbospinal neurons. As illustrated in Fig. 3C, a transient LVA current with a peak amplitude of ~40 pA was evoked at
50 mV from
100 mV with external solution containing 2 mM Ba2+. After replacing Ba2+ with 2 mM Ca2+, the peak amplitude of the LVA current increased to ~120 pA with no apparent change in the kinetics (see Fig. 3C, inset). Similar results were seen in four additional neurons. On average, LVA current (measured at
50 mV from Vh =
100 mV) in 2 mM Ca2+ was approximately twice the size of that in 2 mM Ba2+ (156 ± 38 pA vs.78 ± 24 pA, P < 0.05).
View larger version (21K):
[in a new window]
FIG. 4.
Norepinephrine (NE) inhibits HVA current without affecting LVA current. A: NE (10 µM) inhibited HVA current (21%) but was without effect on LVA current in a bulbospinal neuron. LVA and HVA currents were evoked using the voltage protocol (top). B: averaged data (n = 10) showing that NE significantly inhibited HVA current but had no significant effect on LVA current. *P < 0.05; NS, P > 0.9.
50 mV from a holding potential of
100 mV). Fourteen of these 44 neurons were recovered after histological processing and 12 were TH-IR. Therefore the data from these experiments indicate that most RVLM bulbospinal neurons, including C1 cells, express LVA calcium currents.
2-ARs; activation of
2-ARs hyperpolarized RVLM neurons by increasing an inwardly rectifying K+ conductance (Li et al. 1996
). In a variety of central and peripheral neurons,
2-ARs also mediate inhibition of voltage-activated calcium currents (Chen and Schofield 1993
; Ishibashi and Akaike 1995
; Li and Bayliss 1998
; Trombley 1992
). Therefore we tested if the
2-ARs in RVLM bulbospinal neurons are also coupled to calcium channels.
View larger version (18K):
[in a new window]
FIG. 5.
Concentration- and voltage-dependent inhibition of calcium current by NE. A: effect of different concentrations of NE on calcium channel current in a bulbospinal neuron. Peak currents were plotted as a function of time. B: concentration-response curves. Data points (averaged from 5 to 10 neurons) were fitted with a logistic equation (see text) that predicted an EC50 of 1.2 µM. Only neurons tested with 2 concentrations of NE were included. C: I-V relationship for currents recorded in control and in the presence of 10 µM NE. Sample currents evoked by voltage steps to 0 mV in control and in NE are shown (inset). D: NE-induced inhibition was relieved partially by strong depolarizing prepulses. A double-pulse voltage protocol (top) included a test pulse from
70 to 0 mV before and after a large depolarizing step to +70 mV. Currents evoked by the first and second test pules were similar in amplitude in control. In the presence of NE (10 µM), however, the current evoked by the first test pulse was inhibited to a greater extent than that evoked by the second.
1- and
-AR antagonists, respectively) to eliminate potential effects mediated by those receptors. Because the effects of NE were the same with or without the antagonists present (see further for details on receptor pharmacology), the data were pooled for further analysis. A representative example of the effects of NE on HVA and LVA currents is shown in Fig. 4A. LVA and HVA currents were evoked using a double-pulse protocol (Fig. 4A, top). In the presence of 10 µM NE, LVA current was not noticeably affected, but HVA current (measured isochronally at the control peak current) was inhibited by 21% (Fig. 4A, bottom). We tested effects of NE on both HVA and LVA current in 10 bulbospinal neurons (including 4 TH-IR cells). As illustrated in Fig. 4B, NE (10 µM) inhibited 23 ± 2% of HVA current (P < 0.01) but had no significant effect on LVA current recorded in the same 10 neurons.
c)/[1 + ([NA]/EC50)b] + c}, where a and c are the theoretical minimum and maximum, respectively, and b is a slope function. The calculated EC50 of the inhibition was 1.2 µM.
10 and 0 mV. To explore further the voltage dependence of NE-evoked inhibition, we used a standard double-pulse voltage protocol in which currents were evoked during test pulses to 0 mV from
70 mV, before and after a strong depolarizing prepulse to +70 mV. As seen in Fig. 5D (bottom), under control conditions, calcium current induced by the first and second test pulses were similar in amplitude. However, in the presence of NE, the current evoked during the first test pulse was reduced to a greater extent than during the second test pulse that followed the strong depolarization, and the ratio of those currents increased from 1.0 to 1.4. In six bulbospinal neurons tested, 10 µM NE increased the ratio from 1.1 ± 0.03 to 1.3 ± 0.05 (P < 0.01). These results suggest that the strong depolarizing steps partially relieved calcium current inhibition induced by NE.
2-ARs mediate calcium current inhibition induced by NE
1- and
-AR antagonists, respectively). In the experiment shown in Fig. 6A, NE alone inhibited 34% of peak current; in the presence of prazosin and propranolol (1 µM for both), NE inhibited 39% of the peak currents. There was no significant difference in inhibition induced by NE alone (24 ± 2.1%, n = 18) or in the presence of prazosin and propranolol (27 ± 2.2%, n = 23, P > 0.2, Fig. 6D). Second, we examined the effect of UK 14,304, a selective
2-AR agonist, on calcium current. As exemplified in Fig. 6B, UK 14,304 (1 µM) inhibited 25% of the current in this neuron; on average, 1 µM UK 14,304 inhibited 24 ± 3% of calcium current (n = 6, Fig. 6D). Finally, we tested the effect of the
2-AR antagonist, idazoxan, on calcium current inhibition by NE. In the example shown in Fig. 6C, 10 µM NE inhibited 30% of peak current under control conditions; in the presence of idazoxan (1 µM), however, NE caused only 3% inhibition. After washout of idazoxan, the inhibition of calcium channel current by NE was recovered partially. Grouped data are presented in Fig. 6D. In the presence of 1 µM idazoxan, the NE-induced current inhibition was reduced significantly (from 29 ± 2.1% to 7 ± 1.8%, n = 6; P < 0.01). Results from these experiments indicate that inhibitory effect of NE on calcium current in RVLM bulbospinal neurons is mediated by
2-ARs.
View larger version (23K):
[in a new window]
FIG. 6.
Inhibition by NE of calcium current is mediated by 2-adrenergic receptors (
2-ARs). A: NE (10 µM) in control and in the presence of prazosin and propranolol (
1- and
-AR antagonists, respectively, 1 µM) had a similar inhibitory effect on peak calcium channel current. B: UK 14,304 (1 µM), an
2-AR agonist, produced an inhibition of peak current in a different neuron. C: idazoxan (1 µM), an
2-AR antagonist, attenuated the inhibitory effect of NE (10 µM). Inhibition of NE recovered partially after washout of the antagonist. D: averaged effects on peak current (percent of control) induced by NE alone (n = 41), by NE in the presence of prazosin and propranolol (n = 23), by UK 14,304 (n = 6), and by NE in control and in the presence of idazoxan (n = 6).*P < 0.05.
View larger version (14K):
[in a new window]
FIG. 7.
NE inhibits predominantly N- and P/Q-type calcium currents. A: peak calcium channel currents were plotted as a function of time. NE (10 µM), CgTx (2 µM), AgaTx (0.2 µM), and Cd2+ (100 µM) were applied at the times indicated (solid bars). NE inhibited ~37% of the peak current in control, ~9% after application of CgTx, and ~1.5% after application of AgaTx. Remaining current was abolished during application of Cd2+. B: averaged percentage of NE-sensitive current that was N-type (CgTx-sensitive) and P/Q-type (AgaTx-sensitive) is plotted (left) as is the averaged percentage of N-type (CgTx-sensitive) and P/Q-type (AgaTx-sensitive) current that was inhibited by NE (right). N- and P/Q-type channels contributed most of NE-sensitive current.
). Therefore, we used APWs recorded from RVLM bulbospinal neurons as a voltage command to evoke calcium currents and determined the effects of NE on these APW-induced currents. APW voltage commands were applied at a holding potential of
60 mV, and the peak of APWs reached +20 mV. Figure 8A shows a representative example from one of these experiments. The peak amplitude of leak-subtracted, calcium channel currents evoked by APWs was 1.1 nA. In the presence of 10 µM NE, the peak current was reduced to 0.5 nA (i.e., inhibited by 46%). By contrast, 10 µM NE inhibited only 30% of the peak current evoked by rectangular depolarizing pulses in the same neuron (Fig. 8A, inset). On average, NE inhibited 34 ± 2.5% of peak current evoked by APWs but only 23 ± 2.7% of the current evoked by rectangular depolarizing pulses in the same cells (n = 5; P < 0.05).
View larger version (15K):
[in a new window]
FIG. 8.
NE-induced calcium current evoked by action potential waveforms. A: calcium channel currents were elicited by action potential waveforms (APWs) in control and in the presence of 10 µM NE and leak-subtracted using a P/4 protocol. APWs previously recorded from an RVLM bulbospinal neurons were applied as a voltage command from a holding potential of 60 mV. Inset: currents evoked by rectangular depolarizing steps from a holding potential of
60 mV in the same cell. NE (10 µM) inhibited 46% of peak current evoked by APWs but only 30% of the current evoked by depolarizing steps. B: NE-induced inhibition of currents evoked by a 10-Hz train of APWs (top). Current inhibition induced by NE (10 µM) was not relieved by the spike train.
DISCUSSION
Abstract
Introduction
Methods
Results
Discussion
References
60 mV with a half-inactivation potential of approximately
70 mV, was evident in the majority of bulbospinal RVLM cells. NE inhibited primarily N- and P/Q-type components of HVA current but had no effect on LVA current. NE-induced inhibition was mediated by
2-ARs and was greater when calcium currents were evoked by APWs instead of rectangular depolarizing voltage steps.
). Moreover, A1 noradrenergic neurons that overlap with the caudal pole of the C1 group do not project to the thoracic spinal cord (Westlund et al. 1983
). Therefore, by targeting specifically bulbospinal neurons based on their uptake and retrograde transport of FITC-labeled microbeads injected into the thoracic spinal cord, we avoided those A1 noradrenergic cells. Thus it seems reasonable to conclude that most, if not all, bulbospinal RVLM neurons identified positively as TH-IR indeed represent C1 cells.
30 to
40 mV and a peak amplitude of ~0.8 nA near 0 mV. HVA calcium current was separated into several components according to their sensitivity to calcium channel antagonists. Together, CgTx and AgaTx blocked ~80% of HVA current, indicating that N- and P/Q-type channels accounted for the majority of that current. RVLM bulbospinal neurons also possessed a small amount of dihydropyridine-sensitive L-type calcium current and a small residual current. The residual HVA current may have included some LVA current that was not completely inactivated at the holding potential of
70 mV used in most experiments.
). Serotonergic neurons in the caudal raphe possess primarily N- and P/Q-type currents with essentially no L-type current component (Bayliss et al. 1997b
). Similarly, serotonergic dorsal raphe neurons have no L-type current and a large N-type current but, in contrast to other monoaminergic neurons, they have no P/Q-type current component and express a particularly large toxin-insensitive residual current (Penington and Fox 1995
).
). LVA calcium currents in RVLM cells began to activate at potentials around
60 mV and had rapid inactivation kinetics. Half-inactivation occurred at
70 mV, and the current was inactivated completely at potentials positive to
50 mV. Similar to results from other central neurons (Huguenard and Prince 1992
; Takahashi et al. 1991
), the replacement of Ba2+ with equimolar Ca2+ increased the peak amplitude of LVA currents in RVLM bulbospinal neurons (by ~100%). The pronounced increase in relative current amplitude at
50 mV with Ba2+ or Ca2+ probably represents differences in permeation of the divalent cations through T-type channels (Huguenard and Prince 1992
); it cannot be explained primarily by charge screening effects because Ca2+ substitution would be expected to shift the activation threshold to more depolarized potentials, actually providing less current at the same test potential (Lorenzon and Foehring 1995
).
; Llinas 1988
). Second, LVA current can influence the overall excitability of neurons because it provides a depolarizing influence at subthreshold membrane potentials (Llinas and Yarom 1981
). LVA currents could play a role in the pacemaker activity of bulbospinal RVLM neurons. Although most LVA channels are inactivated at the resting membrane potential (
50 to
55 mV), the high-input resistance of RVLM neurons (~1 G
) would allow a small standing inward current to generate a substantial membrane depolarization (Kangrga and Loewy 1995
; Li et al. 1996
). Moreover, it is conceivable that the afterhyperpolarization (which reaches
70 mV) in RVLM bulbospinal neurons (Kangrga and Loewy 1995
; Li et al. 1996
) could partially remove inactivation of the LVA current, and, in concert with other active properties (e.g., TTX-sensitive persistent sodium conductance) (Kangrga and Loewy 1995
), the LVA current could contribute to the ramp-like depolarization and regular pacemaker-like behavior in these neurons.
2-ARs
; Bayliss et al. 1995
; Ishibashi and Akaike 1995
; Viana and Hille 1996
). The inhibitory effect of NE on HVA currents was concentration-dependent with an EC50 of 1.2 µM and ~25% inhibition at 10 µM NE. Current inhibition was mediated by
2-ARs because the effect was mimicked by the selective
2-AR agonist, UK 14,304, and blocked by the selective
2-AR antagonist, idazoxan, but not affected by prazosin or propranolol (
1- and
-AR antagonists, respectively). The observation that the majority of RVLM bulbospinal neurons (81%) and virtually all C1 neurons (92%) were inhibited by NE and
2-AR agonists is consistent with the results from our previous study, which suggested that most C1 adrenergic neurons express functional
2-ARs (Li et al. 1996
).
2-ARs activate inwardly rectifying K+ channels in C1 adrenergic bulbospinal neurons, causing a membrane hyperpolarization (Li et al. 1996
). Joint modulation of inwardly rectifying K+ channels and voltage-activated calcium channels by G protein-coupled receptors has been demonstrated in other CNS neurons. For example, dopamine (D2) receptors in midbrain dopaminergic neurons (Cardozo and Bean 1995
),
-aminobutyric acid-B receptors in hippocampal neurons (Swartz and Bean 1992
) and serotonin-1A (5-HT1A) receptors in caudal raphe serotonergic neurons (Bayliss et al. 1997a
,b
) can modulate both inwardly rectifying K+ and voltage-activated calcium currents. However, there are examples where G-protein coupled receptors do not modulate both ion channel types. For example, in serotonergic caudal raphe neurons,
2-ARs couple only to voltage-activated calcium channels and not to inwardly rectifying K+ channels even though 5-HT1A receptors modulate both channel types in the same neurons (Bayliss et al. 1997a
,b
; Li and Bayliss 1998
). Thus the differential coupling between
2-ARs and these distinct channel types suggests a functional diversity of signaling mechanisms mediated by
2-ARs in different neurons.
), and it inhibited N- and P/Q-type channels in serotonergic caudal raphe neurons (Li and Bayliss 1997). By contrast, NE inhibited only N-type currents in adrenergic sympathetic postganglionic neurons (Chen and Schofield 1993
).
; Penington et al. 1992
; Toth and Miller 1995
). For example, Penington et al. (1992)
found in dorsal raphe neurons that the inhibitory effect of 5-HT on calcium current was greater when currents were evoked using APWs instead of depolarizing steps. Similarly, Toth and Miller (1995)
showed that NE and neuropeptide Y produced a larger inhibition when calcium currents were evoked by APWs in sympathetic neurons rather than by depolarizing steps. In agreement with these reports, we found that a larger percentage of the calcium current was inhibited by NE when currents were evoked by APWs instead of depolarizing rectangular step commands in RVLM bulbospinal neurons. The enhanced inhibition of calcium current evoked by APWs is probably due to the kinetic slowing that usually accompanies NE-induced inhibition because the shorter duration of the APW limits the voltage- and time-dependent relief of current inhibition that can be seen even during a single voltage step (Penington et al. 1992
).
). This phenomenon may have physiological relevance if, for example, voltage-dependent relief of transmitter inhibition was to occur during a high-frequency burst of spikes. For this reason, we examined the inhibition by NE of calcium currents evoked by a train of APWs (10 Hz, 0.8-s duration) to determine if any relief occurred during the APW train. We chose a frequency of 10 spikes/s because it is close to the maximal spike frequency that neonatal C1 adrenergic neurons attained after application of neurotransmitters such as angiotensin II and substance P (Li and Guyenet 1996
, 1997
). We found thatNE-evoked inhibition of calcium currents was not relieved during the course of the APW train. These results are in accord with the observations of Toth and Miller (1995)
and Penington et al. (1991)
, who showed that neither trains of short rectangular pulses designed to mimic APWs nor a long train of APWs (even at frequencies as high as 75 Hz) changed the degree of transmitter-induced inhibition in dorsal raphe and sympathetic neurons. On the other hand, results from two recent papers suggest that relief of transmitter-induced inhibition can occur during simulated spike firing but that the degree of relief varies considerably depending on the characteristics of the discharge (i.e., firing rate and pattern, action potential duration) (Brody et al. 1997
; Williams et al. 1997
). However, the discharge rates that supported significant relief of transmitter-induced inhibition in those studies were outside the range of steady state firing frequency of bulbospinal RVLM neurons in vitro (Li et al. 1996
).
2-ARs
2-ARs to inwardly rectifying K+ channels may represent a mechanism by which C1 neurons, which synthesize and probably release catecholamines, can regulate their discharge rate
a so-called "autoinhibition" (Li et al. 1996
). The inhibition of voltage-activated calcium currents by
2-ARs that we report here may represent an additional autoinhibitory mechanism. Ultrastructural studies demonstrate that PNMT-IR terminals form occasional synaptic contacts with PNMT-IR cell bodies in the RVLM, suggesting that C1 adrenergic neurons send collateral projections onto themselves or neighboring cells (Miller 1994). Electrochemical detection of catecholamine metabolites in vivo suggests that release of catecholamines in the RVLM correlates with the activity of C1 neurons and may originate from those cells (Mermet and Quintin 1991
; Rentero et al. 1993
). In addition, clonidine, an
2-AR agonist that is known to inhibit activity of C1 neurons, also inhibited release of catecholamines in RVLM. Although clonidine could inhibit spike-dependent catecholamine release from C1 neurons via
2-AR-mediated inhibition of firing activity, it also might act by inhibiting the calcium currents that support release. In addition, inhibition of calcium current by
2-ARs also could reduce transmitter release from bulbospinal RVLM cells in the spinal cord if
2-ARs, as well as N- and P/Q-type calcium channels, are present on terminals of C1 neurons.
2-ARs could alter the firing behavior of the bulbospinal RVLM neurons. In serotonergic caudal raphe neurons and in somatic motoneurons, inhibition of calcium currents by 5-HT decreases the amplitude of the spike afterhyperpolarization and increases the firing frequency response to current inputs (Bayliss et al. 1995
, 1997b
). As suggested for 5-HT effects on serotonergic raphe neurons, if NE hyperpolarizes C1 neurons (via
2-AR-mediated activation of inwardly rectifying K+ conductance) and simultaneously enhances spike firing responses to current inputs (via
2-AR-mediated inhibition of calcium current and afterhyperpolarization), the functional consequence would be to increase the signal-to-noise ratio of synaptic inputs (i.e., effects of strong, suprathreshold inputs would be enhanced by NE, whereas effects of weak inputs would be attenuated).
![]() |
ACKNOWLEDGEMENTS |
---|
The authors gratefully acknowledge the contributions of N. Sadr and R. Ogle for help with immunostaining tissue sections; we thank Pfizer Central Research for the gift of -agatoxin IVA.
This work was supported by National Institutes of Health Grants HL-28785 to P. G. Guyenet and NS-33583 and American Heart Association Grant 96010950 to D. A. Bayliss.
![]() |
FOOTNOTES |
---|
Present address of Y.-W. Li: Bio-Control Systems Group, Dupont Experimental Station, E328/B29, Wilmington, DE 19880-0328.
Address for reprint requests: D. A. Bayliss, Dept. of Pharmacology, Box 448, 5017 Jordan Hall, University of Virginia, Charlottesville, VA 22908.
Received 28 August 1997; accepted in final form 13 October 1997.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|